Testimony by Dr. Edward Gomperts, medical director and vice president of medical affairs and clinical development at the Hyland division for Baxter Healthcare Corporation (Baxter). Discusses chairman initiatives, plasma pool sizes, locations of plasma centres, product recalls due to concerns about Creutzfeldt-Jakob disease, and viral inactivation.